AUS
NZ
UK
CA
USA
IND
Healthcare
4basebio Expands Scientific Expertise for the Future of Genetic Medicine
June 15, 2026 02:15 PM BST| By Vivek Singh4basebio (LSE:4BB) expands its scientific capabilities with a strategic advisory appointment, supporting innovation in synthetic DNA technologies for mRNA therapeutics, gene editing, and advanced genetic medicine development.
Haleon (LSE:HLN) Advances Capital Strategy with Share Cancellation Initiative
June 15, 2026 12:44 PM BST| By Vivek SinghHaleon (LSE:HLN) continues its share cancellation initiative as part of a broader capital management strategy, reinforcing transparency, governance standards, and long-term shareholder value creation.
FDA Approval Opens New Chapter for AstraZeneca’s Oncology Growth
June 14, 2026 06:24 PM BST| By Vivek SinghFDA approval of TRUQAP strengthens AstraZeneca’s precision oncology portfolio, highlighting advances in targeted prostate cancer treatment and the growing importance of biomarker-driven healthcare solutions.
Sponsored
Can Fusion Antibodies Plc Turn Innovation into Sustainable Revenue Growth?
June 15, 2026 01:59 PM BST| By Ishan MudgalFusion Antibodies Plc operates in the biotechnology sector and specializes in antibody discovery, engineering, optimization, and humanization services. The company serves pharmaceutical and biotechnology clients involved in developing next-generation antibody-based therapeutics.
AI Healthcare Revolution: Three UK Stocks Worth Watching
June 12, 2026 01:57 PM BST| By Vivek SinghDiscover how artificial intelligence is transforming healthcare innovation and explore the role of IXICO, AstraZeneca, and EMV Capital in advancing diagnostics, drug development, and healthcare technology.
How Cizzle Biotechnology’s US Patent Could Shape Lung Cancer Diagnostics
June 12, 2026 01:20 PM BST| By Vivek SinghCizzle Biotechnology secures a US patent for its lung cancer biomarker technology, supporting commercial expansion, strengthening intellectual property protection, and advancing early detection solutions in global healthcare markets.
BSF Enterprise Strengthens Bio-Leather Momentum Across Global Industries
June 12, 2026 09:15 AM BST| By Vivek SinghBSF Enterprise explores new opportunities for its bio-leather technology as luxury, automotive, and sportswear sectors continue evaluating advanced sustainable material solutions.
Sponsored
What Is Driving the Rise in Fusion Antibodies Shares?
June 15, 2026 11:53 AM BST| By Ankur SharmaWhy Is FAB - Fusion Antibodies PLC Stock Rising in June 2026?
Can Healthcare Shares Really Shelter Portfolios From Geopolitical Storms?
June 11, 2026 11:38 AM BST| By Vivek SinghWith London indices near multi-week lows on Middle East tension, investors are leaning on defensive sectors. We examine whether UK healthcare shares are living up to their safe-haven billing.
Is UK Pharma Quietly Building Its Next Generation of Blockbusters?
June 11, 2026 11:35 AM BST| By Vivek SinghFrom oncology dealmaking to obesity research and regulatory milestones, Britain's listed drugmakers are locked in a race to refill their pipelines — a contest now shaping the UK healthcare sector's narrative.
AstraZeneca and GSK in Focus as Regulatory and Deal News Stirs UK Healthcare
June 11, 2026 11:29 AM BST| By Vivek SinghUK healthcare shares are in the spotlight as AstraZeneca faces an extended regulatory timeline for a key oncology filing and GSK digests reaction to a major acquisition, all against a risk-off London market.
Sponsored
Why Has HemoGenyx Fallen Despite Biotechnology Innovation?
June 15, 2026 11:39 AM BST| By Divya SoodHemoGenyx Pharmaceuticals Plc (LSE:HEMO) is trading lower today as investors continue reassessing risk across the biotechnology sector, particularly among early-stage clinical-development companies. Like many small-cap biotech businesses, the company's valuation is heavily influenced by clinical progress, regulatory developments, funding requirements, and investor sentiment toward …
Why Healthcare Stocks Are Back In The London Conversation
June 11, 2026 10:37 AM BST| By Vivek SinghHighlights,Healthcare Stocks are active in the UK conversation as london trading has been shaped by a cautious mood as investors weigh middle east headlines, oil moves, and the timing of the next major central-bank signals.,London-listed names such a...
Healthcare Stocks Face A New Test From London Sentiment
June 11, 2026 10:37 AM BST| By Vivek SinghHighlights,Healthcare Stocks are active in the UK conversation as london trading has been shaped by a cautious mood as investors weigh middle east headlines, oil moves, and the timing of the next major central-bank signals.,London-listed names such a...
Healthcare Stocks And The Sector Shift Shaping Attention
June 11, 2026 10:37 AM BST| By Vivek SinghHighlights,Healthcare Stocks are active in the UK conversation as london trading has been shaped by a cautious mood as investors weigh middle east headlines, oil moves, and the timing of the next major central-bank signals.,London-listed names such a...
Sponsored
Are Commercialisation Risks Affecting AOTI Stock?
June 15, 2026 11:38 AM BST| By Divya SoodAOTI, Inc. (LSE:AOTI) is trading lower today as investors continue evaluating growth expectations, commercial execution risks, reimbursement dynamics, and broader sentiment toward smaller healthcare-technology companies. While the company operates within the attractive advanced wound-care market, investors remain focused on the pace of adoption and …
What's Behind the Flurry of Regulatory Wins for UK Pharma Giants?
June 10, 2026 12:09 PM BST| By Vivek SinghA wave of regulatory milestones, from AstraZeneca's oncology approvals to GSK's respiratory green lights in Asia, has kept UK healthcare companies in the headlines as investors digest a busy news cycle.
From Lab Bench to Blue Chips: The Hidden Engine of London's Healthcare Scene
June 10, 2026 12:05 PM BST| By Vivek SinghThe UK healthcare sector is evolving beyond its defensive reputation, with regulatory reform, oncology breakthroughs and life sciences innovation reshaping how London-listed pharma, medtech and consumer health companies are perceived by investors.
Why Are Healthcare Shares Stealing the Spotlight as the FTSE Flirts With Records?
June 10, 2026 12:00 PM BST| By Vivek SinghHealthcare shares drew attention as London's blue-chip index hovered near record territory, with pharmaceutical heavyweights, medical device makers and consumer health names all featuring among the session's most-watched movers.
Sponsored
Are Clinical Risks Hurting ImmuPharma Stock?
June 15, 2026 11:38 AM BST| By Divya SoodImmuPharma plc (LSE:IMM) is trading lower today as investors continue evaluating clinical-development progress, funding requirements, regulatory pathways, and broader sentiment toward early-stage biotechnology companies. Like many development-stage biotech businesses, the company's valuation is driven more by future expectations than by current revenue generation.
What Is Shaping The Conversation Around Healthcare Stocks
June 10, 2026 08:18 AM BST| By Vivek SinghThis article covers Healthcare Stocks UK markets company examples sector themes index context regulation commercial updates and neutral market discussion today across London listed shares.
Why Are Healthcare Stocks Being Discussed Across London Shares
June 10, 2026 08:18 AM BST| By Vivek SinghThis article covers Healthcare Stocks UK markets company examples sector themes index context regulation commercial updates and neutral market discussion today across London listed shares.
Why Are Healthcare Stocks Drawing Attention In UK Markets
June 10, 2026 08:17 AM BST| By Vivek SinghThis article covers Healthcare Stocks UK markets company examples sector themes index context regulation commercial updates and neutral market discussion today across London listed shares.
Sponsored
Is MedPal AI the Next Big AI Healthcare Winner or Speculative Bubble?
June 15, 2026 11:19 AM BST| By Ankur SharmaWhy Is MPAL - MedPal AI PLC Stock Rising in June 2026?
The Ageing World That Underpins Healthcare Demand
June 09, 2026 11:28 AM BST| By Vivek SinghBeyond their defensive qualities, healthcare shares benefit from a powerful demographic tailwind, as ageing populations across the developed world drive steadily rising long-term demand for medicines and care.
Why A Drug Patent Clock Keeps Pharma Bosses Awake
June 09, 2026 11:25 AM BST| By Vivek SinghThe fortunes of UK pharmaceutical giants hinge on their drug pipelines and the protection on existing products, a constant cycle of innovation and expiry that defines one of the market's most research-intensive sectors.
